Skip to content
Open access

Integrating single-cell and bulk RNA data to explore the prognostic significance of LIM domain family genes in colorectal cancer and unveil their immune landscape

Aug 2026 · Translational Oncology · Vol 72, pp. 102974 · 0 citations · 73 references
Medicine

TL;DR

It was revealed that cells with high LIM scores were predominantly fibroblasts, and Erlotinib, fulvestrant, EPZ5676, and AZD1208 were identified as potential therapeutic agents for patients in the low-LIMRS group, whereas vinblastine, docetaxel, paclitaxel, and vinorelbine may be more suitable for high-LIMRS group patients.

Abstract

Highlights • This study revealed that cells with high LIM scores were predominantly fibroblasts.• A risk model constructed from nine LIM domain family signature genes (CRYAB, RGS16, CSRP2, RCAN2, TPM1, EGFL7, PLS3, PDGFRA, and PLAU) accurately predicted the prognosis of CRC patients.• Erlotinib, fulvestrant, EPZ5676, and AZD1208 were identified as potential therapeutic agents for patients in the low-LIMRS group, whereas vinblastine, docetaxel, paclitaxel, and vinorelbine may be more suitable for high-LIMRS group patients.

Read PDF

Similar papers

Open access Sep 2026

Prognostic value of neuro-related genes in colorectal cancer and their potential implications for immunotherapy

Colorectal cancer (CRC) remains a leading cause of cancer mortality. This study investigates the prognostic and immunological role of neural-related genes (NRGs) in CRC. Using The Cancer Genome Atlas (TCGA) data, a four-gene signature (POU4F1, KLC3, ATP2A1, CALB2) was constructed via Cox and least absolute shrinkage an...

Huan-Tong Wu, Wei-Hua Liu, Sheng-Tao Zhu · 0 citations
Open access Sep 2026

Integrated single-cell and bulk transcriptomic analysis reveals an epithelial cell-derived prognostic and immunotherapeutic signature with ADAM12 as a key functional regulator in non-small cell lung cancer

Highlights • Single-cell transcriptomics reveals epithelial heterogeneity shaping NSCLC immunity.• A 101-algorithm ML framework constructs a Prognostic and Immunotherapeutic Signature.• PIS stratifies NSCLC patients by prognosis and immune checkpoint blockade response.• ADAM12 inhibition enhances anti-PD-1 efficacy in...

Hai-Lin Liu, Jun-Jie Yu, Yan-Tao Jiang et al. · 0 citations
Sep 2026

Identification of anoikis-related and cell matrix adhesion genes in the progression of colon adenocarcinoma using bioinformatics analysis.

To develop an innovative prognostic model for colon adenocarcinoma (COAD), we integated anoikis- and cell matrix adhesion (CMA related mechanisms using TCGA and GEO datasets. Six genes (BST2, NAT1, OFCC1, HOTAIR, TRIP6, ADAMTS13) were identified, risk model stratified patients into high- and low risk groups with distin...

Ting Zheng, Xing-Xing Li, Li Zhou et al. · 0 citations
Open access Aug 2026

Integration of single-cell transcriptomics and genomic mutation analysis identifies an immunotherapy-resistant tumor subcluster and validates ARNTL2 as a malignant driver in lung adenocarcinoma

Single-cell sequencing reveals resistance-linked malignant subcluster in LUAD, confirming oncogenic role and CoxBoost + survivalSVM model achieves optimal C-index of 0.686 across seven cohorts.

Z. Qiu, Hui Zhao, Qiong Lyu et al. · 0 citations
Open access Aug 2026

Single-cell and bulk transcriptomic profiling of M2-like tumor-associated macrophages reveals a prognostic signature and an inflammation–metabolism crosstalk program in multiple myeloma

Highlights • Seven MM-specific M2-TAM subsets (MM-M2) are absent in normal bone marrow.• MM-M2 subclusters exhibit distinct transcription factor programs via SCENIC.• Enhanced ligand–receptor signaling links MM-M2 to plasma and stromal cells.• An 11-gene RSF-derived MRGs signature stratifies MM patients by survival.• M...

Hui Zhao, Jing Kang, H. Ouyang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.